Cosentyx (secukinumab) — Point32Health

Initial criteria

• Documented diagnosis of plaque psoriasis
• Patient age ≥ 6 years
• Prescribed by or in consultation with a dermatologist
• Documentation of one (1) of the following: (a) Trial and failure of at least two of the listed medications from each of the following therapeutic categories (only one medication is required if only one is available for that category): Interleukin Antagonists (Bimzelx, Skyrizi, Taltz, Tremfya, Yesintek), Phosphodiesterase 4 inhibitors (Otezla), Tumor Necrosis Factors (Cimzia, Enbrel, Humira); OR (b) Contraindication to all of the following medications: Bimzelx, Skyrizi, Taltz, Tremfya, Yesintek, Otezla, Cimzia, Enbrel, Humira